<DOC>
	<DOCNO>NCT02068300</DOCNO>
	<brief_summary>The purpose study evaluate usefulness plasma 1,5-anhydro-D-glucitol ( 1,5-AG ) novel surrogate marker hypoglycemia</brief_summary>
	<brief_title>The Role 1.5-anhydro-D-glucitol Clinical Biomarkers Hypoglycemia Patients With Diabetes</brief_title>
	<detailed_description>We enrol well control diabetes patient hypoglycemic event least one time . All patient assess risk severe hypoglycemia hypoglycemic unawareness use hypoglycemic awareness questionnaire ( HYPO score ) . The patient treat insulin agent insert sensor continuous glucose monitor system skin three day . We analyse correlation 1,5-anhydro-D-glucitol HYPO score .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Sorbitol</mesh_term>
	<criteria>patient attend outpatient department endocrinology metabolism , seoul national university hospital . ( HbA1C &lt; 8 % ) The patient treat insulin sulfonylurea least 3month period In case fo sulfonylurea user , HbA1c restrict 8 % The patient hypoglycemic event least 3 month survey questionnaire insert continuous glucose monitoring system renal dysfunction patient hepatic dysfunction patient kind disease , operation , medical treatment affect glucose level</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>1,5-anhydro-D-glucitol , hypoglycemia , surrogate marker</keyword>
</DOC>